CNS vs WHG

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 10, 2026

CNS

53.9
AI Score
VS
CNS Wins

WHG

45.7
AI Score

Investment Advisor Scores

CNS

54score
Recommendation
HOLD

WHG

46score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric CNS WHG Winner
Revenue 94.41M 50.31M CNS
Net Income 29.96M 2.31M CNS
Net Margin 31.7% 4.6% CNS
Operating Income 36.29M 568,000 CNS
ROE 9.9% 1.8% CNS
ROA 6.7% 1.5% CNS
Total Assets 450.12M 155.38M CNS
Cash 193.73M 22.62M CNS
Free Cash Flow 4.31M 2.24M CNS

Relative Price Performance (Last 90 Days)

CNS 1M: -11.6% · 3M: -1.4% WHG 1M: -2.1% · 3M: +6.8%

Current Technical Phase

CNS

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 33

RSI (14): 32.6 · Price: $74.95

WHG

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 42

RSI (14): 41.9 · Price: $18.79

Fundamentals Snapshot

Metric CNS WHG
Market Cap
Forward P/E 18.8 24.9
Trailing P/E 23.7 21.5
Revenue (TTM)
Revenue Growth 0.1% 0.1%
Gross Margin 0.5% 0.4%
Operating Margin 0.3% 0.1%
EPS 3.23 0.87
Dividend Yield 0.03% 0.03%

Frequently Asked Questions

Based on our detailed analysis, CNS is currently the stronger investment candidate, winning 9 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.